The unintended stimulation/new pain questionnaire was reviewed for potential causes of the reported issue.Based on this review, the script was completed with limited information.Based on this review, the stimulator being implanted in an off-label location was ruled out as a potential cause.The senior manager, clinical research reported this event is not related to the stimwave device.The stimulator is used to treat pain.The cause of the reported issue is unknown.The provided information does not evidence that the stimwave device contributed to the issue.Investigation conclusion has been attributed to clinician user error due to improper patient selection/inadequate evaluation of pre-existing conditions prior to implant.Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in other adverse events issues.Other adverse events issues rates remain acceptably low; thus, capa is not required. other adverse events issues rates will continue to be tracked and trended.
|
A freedom-1 clinical study patient was admitted to the hospital due to shortness of breath and chest pain.They were diagnosed with blood clots.The patient was prescribed eloquis and will have a ct scan performed in the next two weeks to monitor the blood clots.Additionally, the patient is diabetic, has high cholesterol, and high blood pressure.The patient has been caring for their spouse which caused edema.Water pills were prescribed for this condition.
|